SELECT
LIVE

Serial Number

97551508

Owner

OLYMPUS CORPORATION

Attorney

Susan M. Kornfield

Filing Date

Aug 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SELECT Trademark

Serial Number: 97551508

SELECT is a trademark filed by OLYMPUS CORPORATION on August 16, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently pending registration.

Owner Contact Info

OLYMPUS CORPORATION (973 trademarks)

2951 Ishikawa-machi, Hachioji-shi
TOKYO , JP

Entity Type: 09

Trademark Details

Filing Date

August 16, 2022

Registration Date

Not Registered

Published for Opposition

February 6, 2024

Goods & Services

Downloadable reports and documents in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the visual readings of lung structures; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; downloadable reports and documents featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

Printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation, surgical treatment, and medical treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine and quantitative computed tomography analysis; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures to support visual readings of lung structures; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

Providing medical information regarding medical devices for the treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease; medical diagnostic testing, monitoring and reporting services in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; medical information services, namely, analysis and reporting services relating to the treatment of patients based on quantitative measurements of computed tomography scans in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing online medical record analysis services designed to provide patients and practitioners with customized data used to inform and recommend treatment options in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing a website featuring online medical information regarding medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

Providing temporary use of online non-downloadable software for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of online non-downloadable software featuring artificial intelligence for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of on-line non-downloadable software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease and generating reports corresponding to the foregoing; software as a service (SAAS) services featuring software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease, and generating reports corresponding to the foregoing; software as a services (SAAS) services featuring software for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring software using artificial intelligence for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing and submitting medical information in the form of computed tomography scans, receiving quantitative data analysis of computed tomography scans, and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures to support visual readings of lung structures, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

Filing History

TEAS STATEMENT OF USE RECEIVED
Sep 30, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 1, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 1, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 17, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 17, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 31, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 21, 2023 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 11, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 13, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 13, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 13, 2023 CNSL
EXAMINER'S AMENDMENT ENTERED
Jun 13, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 13, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 13, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 13, 2023 CNEA
ASSIGNED TO EXAMINER
Jun 2, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2022 NWOS
NEW APPLICATION ENTERED
Aug 19, 2022 NWAP